Core Points - The company plans to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares to all shareholders based on the total share capital as of the dividend distribution date [1][2] - The total share capital as of June 30, 2025, is 1,038,836,522 shares, with adjustments to be made if there are changes in share capital due to convertible bonds, share buybacks, or other significant events [1] - The profit distribution plan is subject to approval by the shareholders' meeting [2] Company Overview - The company is listed on the Shanghai Stock Exchange under the stock code 600062, with the stock name "华润双鹤" [3] - As of the end of the reporting period, the total assets amount to approximately 16.74 billion yuan, showing a slight increase of 0.33% compared to the previous year [3] - The net assets attributable to shareholders increased by 6.08% year-on-year, reaching approximately 11.04 billion yuan [3] Financial Performance - The company's operating revenue for the reporting period is approximately 5.74 billion yuan, a decrease of 3.16% compared to the same period last year [3] - The total profit for the period is approximately 1.22 billion yuan, reflecting a growth of 2.05% year-on-year [3] - The net profit attributable to shareholders decreased by 6.79% to approximately 975.49 million yuan [3] - The net cash flow from operating activities decreased by 29.24% to approximately 662.17 million yuan [3] - The basic and diluted earnings per share are both 0.9480 yuan, down by 7.05% compared to the previous year [3] Shareholder Information - The largest shareholder is Beijing Pharmaceutical Group Co., Ltd., holding 60.24% of the shares [4] - The total number of shareholders as of the reporting period is 57,431 [3]
华润双鹤: 华润双鹤2025年半年度报告摘要